Entero Therapeutics, Inc. Quarterly Deferred Income Tax Liabilities, Net in USD for Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Entero Therapeutics, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate for Q1 2024.
  • Entero Therapeutics, Inc. Deferred Income Tax Liabilities, Net for the quarter ending March 31, 2024 was $571K.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $571K Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.